News Apr 17, 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News Apr 04, 2024 Galderma completes largest IPO on a global level in Q1 Galderma has banked nearly 2.3 billion Swiss francs following its listing on the SIX Swiss Exchange. The pharma firm was therefore responsible fo...
News Mar 26, 2024 Zurich researchers make cancer therapy effective again Researchers from the University of Zurich and University Hospital Zurich have discovered how mutated blood cancer cells can be made to respond to...
News Mar 13, 2024 PSI developing new cancer therapy Researchers from the Paul Scherrer Institute (PSI) have developed a radiopharmaceutical to combat metastatic neuroendocrine tumors. After having ...
News Feb 14, 2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
Press Release Jan 30, 2024 Exports stagnant: Swiss companies adjust their expectations and strategies Swiss SMEs are still expecting minimal export growth in the coming months. This is the finding of the latest survey of Swiss SMEs conducted by Sw...
News Jan 29, 2024 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
News Jan 10, 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News Dec 22, 2023 Zynnon hits milestone in the diagnosis of respiratory infections Zynnon has reached a milestone with its technology for diagnosing viral respiratory infections. Following successful studies in hospitals, the co...
News Dec 19, 2023 Top Stories from Western Switzerland (October-December 2023) From achieving top rankings in global innovation to making significant advancements in healthcare and technology, discover Western Switzerland's ...
News Dec 11, 2023 Artbio and Scailyte making headlines in Basel The biotech company Scailyte has raised 8 million US dollars as part of a Series A financing round. For its part, Artbio has raised as much as 90...
News Dec 11, 2023 Cytiva’s strategic expansion in Western Switzerland’s Health Valley Cytiva, a global life sciences leader, has recently bolstered its operations in the Health Valley through a strategic merger with Pall Life Scien...
News Dec 04, 2023 Siegfried, a Swiss leader taking innovations to industrial scale for the pharmaceutical industry From a small operation in Aargau to a global CDMO powerhouse, Siegfried's journey reflects strategic growth, innovation, and a deep commitment to...
News Nov 10, 2023 Researchers heal wounds with lactobacilli Researchers from Switzerland and the USA have jointly developed a dressing that uses probiotics to eliminate pathogens in chronic wounds. The pro...
News Nov 06, 2023 Investors stump up 3.7 million Swiss francs in Onena Medicines Onena Medicines has secured investment of 3.7 million Swiss francs. The portfolio company of the biotech start-up incubator BaseLaunch will there...
News Nov 03, 2023 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
News Nov 01, 2023 Palto Therapeutics receives 150,000 Swiss francs from Venture Kick Palto Therapeutics has won the third stage of the Venture Kick promotional funding program. As such, the company now stands to benefit from 150,0...
News Nov 01, 2023 Bacthera’s Visp plant aims to revolutionize microbiome-based treatments In Visp, Bacthera’s MC4a Center of Excellence readies to manufacture transformative microbiome therapies, notably the Seres Therapteutics’ life-s...